• #228 | How to Prove Your MedTech Commercialisation Strategy Is Actually Working
    2026/09/08

    How do you know whether your MedTech commercialisation strategy is actually working?

    Regulatory approval, clinical evidence, distributor appointments, customer meetings and even your first sale can all feel like signs of commercial progress. But for MedTech founders trying to build, commercialise and eventually export a medical device, there's a difference between creating the conditions for commercial success and proving you have a sustainable business. In this episode, Hakeem uses an unlikely lesson from 90s hip-hop to explore what really counts as commercial success—and why the ability to repeat a sale matters so much.

    In this episode you'll discover:

    • How to distinguish between activities that support MedTech commercialisation and the evidence that your commercial model is actually working.
    • Why making your first medical device sale is only part of the story—and what repeatability tells you about whether you've built a sustainable business.
    • How working backwards from the money can help you understand the decision-makers, budgets, beliefs and buying process required to generate sales repeatedly.

    Action

    Listen now to discover how to measure whether your MedTech commercialisation strategy is genuinely working and identify what needs to happen to turn individual sales into a repeatable commercial model.

    Book a 30min Healthcare Export Accelerator discovery call

    Message me via DM on Linkedin

    This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

    続きを読む 一部表示
    8 分
  • #227 | Why the Biggest Export Market May Be the Wrong Market for Your MedTech Product (for Clinicians)
    2026/09/03

    How do you know which international markets actually give your MedTech product the best chance of success?

    This avoids the problem we've discussed before: it doesn't tell the listener what they're doing wrong. It opens the question the episode answers.

    When you're ready to export your MedTech product, it's tempting to start with the biggest healthcare markets, the fastest-growing countries or places where you already know distributors. But the right export market for one medical device could be completely wrong for another. In this episode, Hakeem explains why effective international market selection starts by understanding your product, what drives adoption and the specific commercial conditions that need to exist in each market before you decide where to expand.

    In todays episode you'll discover:

    • Why the biggest or most attractive-looking international market isn't necessarily the best export opportunity for your MedTech product.
    • How factors including clinician adoption, competition, evidence, reimbursement, pricing, buying pathways and your commercial model can change which markets you should prioritise.
    • How to assess both market potential and your probability of successfully entering it, rather than choosing countries based on market size alone.

    Listen now to learn how to choose the right export markets for your MedTech product by focusing on where you have both an attractive commercial opportunity and a realistic probability of achieving adoption.

    Book a 30min Healthcare Export Accelerator discovery call

    Message me via DM on Linkedin

    This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

    続きを読む 一部表示
    13 分
  • #226 | Why Your MedTech Product May Be Ready to Launch But Not Ready to Sell
    2026/09/01

    Your medical device has regulatory approval, clinical evidence and manufacturing in place but does that actually mean customers are ready to buy it?

    This doesn't diagnose their problem. It challenges the assumption that the three green ticks automatically equal commercial readiness.

    A MedTech product can be completely ready to launch and still not be commercially ready to sell. Before spending heavily on salespeople, distributors, exhibitions or new export markets, you need to know whether customers have genuine demand, how your medical device actually gets bought, and what could make adoption harder than expected. In this episode, Hakeem explains how to assess your commercial readiness before scaling a go-to-market strategy that may not yet work.

    In this episode you'll discover:

    • How to distinguish genuine customer demand from positive feedback and interest before investing heavily in commercialisation.
    • Why understanding the complete buying pathway—from clinicians and other decision-makers to evidence, procurement and budgets—is critical to turning interest into revenue.
    • How to identify adoption friction and stress-test your go-to-market model before adding more salespeople, distributors or export markets.

    Listen now to discover whether your MedTech product is genuinely ready to sell—and what you need to fix before investing more money in commercialisation, adoption and international growth.

    Message me via DM on Linkedin

    Take the CPI Quiz to see how commercially ready your product is

    This podcast is for clinicians feeling stuck in turning medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, and to scale up their international sales in MedTech.

    続きを読む 一部表示
    22 分
  • #225 | How to Enter the US MedTech Market Without Wasting Your Export Budget
    2026/08/27

    If you had £500,000 to enter the US with your MedTech product, where would you spend it first?

    For clinician founders looking to export a medical device to the US, the size of the opportunity can make it tempting to think big from day one. But entering the US MedTech market and scaling across it are two very different decisions. In this episode, Hakeem and international growth and commercialisation consultant Craig T. Ingram explore whether you should build a US sales team, appoint a distributor, raise more capital or prove your commercial model in one defined market segment first.

    In this episode you'll discover:

    • Why treating the US as one enormous MedTech market can lead to expensive commercial and export decisions.
    • How proving your commercial model in one defined US customer segment can help you understand acquisition costs, adoption pathways and whether your product can actually make money before you scale.
    • Why hiring a sales team, appointing a distributor or raising more capital shouldn't substitute for first understanding exactly where, how and why your medical device will sell in the US.

    Listen now to discover how to approach US MedTech market entry, prove your commercial model and make your export budget work harder before committing significant capital to scaling.

    Book a 30min Healthcare Export Accelerator discovery call

    Message me via DM on Linkedin

    This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

    続きを読む 一部表示
    11 分
  • #224 | How to Grow Your MedTech Business Without Throwing Money at Sales
    2026/08/25

    What if spending more money on sales isn't actually the fastest way to grow your MedTech business?

    For clinician founders looking to commercialise and export a medical device internationally, growing a MedTech business takes more than regulatory approval, investment and an expensive sales team. If the market doesn't understand the problem your product solves or have a reason to change, adding salespeople can simply increase your burn rate without increasing adoption. In this episode, Hakeem speaks with international growth and commercialisation consultant Craig T. Ingram about creating demand before launch, entering new export markets and building a commercial model capable of sustainable international growth.

    By listening you'll discover:

    • Why MedTech commercialisation needs to start long before regulatory approval and product launch.
    • Why spending heavily on salespeople isn't the same as building a market—and what needs to happen first to create demand.
    • Why proving your commercial model, controlling your burn rate and executing consistently can be more important than trying to scale quickly.

    Action

    Listen now to discover how to grow your MedTech business by creating demand first, spending your commercial resources more intelligently and building a model that can scale sustainably.

    Book a 30min Healthcare Export Accelerator discovery call

    Message me via DM on Linkedin

    This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

    続きを読む 一部表示
    48 分
  • #223 | 5 Things You Need to Know Before Exporting Your MedTech Product to the GCC (for Cinicians)
    2026/08/20

    Thinking about exporting your MedTech product to the GCC? Are you actually ready to build a market there or are you simply looking for a distributor?

    Successfully exporting a MedTech product to the GCC takes more than appointing a distributor and waiting for sales. You need clear clinical value, the right commercial partner, a plan for creating demand, meaningful measures of early progress, and ongoing manufacturer support. In this episode, Hakeem shares five key lessons from his conversation with experienced GCC distributor Sameh Salama to help you prepare for commercialisation, adoption and sustainable sales across the region.

    Listen to discover:

    • Why strong clinical value and evidence need to come before approaching GCC distributors.
    • How to choose the right distributor, create demand and measure the activities that lead to adoption and sales.
    • Why successful MedTech export requires ongoing manufacturer support rather than expecting your distributor to build the market alone.

    Action

    Listen now to discover the five things you need to get right before exporting your MedTech product to the GCC and give yourself a stronger foundation for adoption and sustainable sales.

    Book a 30min Healthcare Export Accelerator discovery call

    Message me via DM on Linkedin

    This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

    続きを読む 一部表示
    7 分
  • #222 | How to Make Your MedTech Product Attractive to Export Distributors
    2026/08/18

    If a great export distributor had four MedTech products to choose from today, why would they choose yours?

    MedTech manufacturers spend a lot of time asking whether a distributor is capable of selling their product. But there's another question that's just as important: why should a good distributor choose you? Taking on your product means investing their sales time, clinical resources, customer relationships, marketing activity and reputation. In this episode, Hakeem unpacks a real decision with experienced GCC distributor Sameh Salama to reveal what good export distributors actually look for before deciding whether a MedTech product represents a genuine commercial opportunity.

    Listen to this episode to discover:

    • Why strong clinical evidence matters to export distributors but isn't enough on its own to create a compelling commercial opportunity.
    • What good distributors assess before agreeing to represent your MedTech product—and why a distributor who challenges you can actually be a very positive sign.
    • Why successful MedTech commercialisation and export depends on the manufacturer and distributor working together to create demand, rather than expecting the distributor to build the market alone.

    Listen now to discover what good export distributors really look for and how to make your MedTech product a commercial opportunity they'll want to invest their time, resources and relationships in.

    Book a 30min Healthcare Export Accelerator discovery call

    Message me via DM on Linkedin

    This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

    続きを読む 一部表示
    11 分
  • #221 | How to Export Your MedTech Product to the GCC Successfully (For Clinicians)
    2026/08/13

    Thinking about exporting your MedTech product to the GCC? What if finding a great distributor is only the beginning of what you need to succeed?

    The GCC can be an attractive export market for MedTech companies, but you can't simply take the strategy that worked in the UK, Europe or US, appoint a distributor and expect the same results. In this episode, Hakeem speaks with GCC MedTech distributor Sameh Salama about what manufacturers need to understand before entering the region, from choosing the right commercial partner and navigating local purchasing dynamics to clinical education, KOL engagement and supporting your distributor after launch.

    By listening you'll discover:

    • Why the GCC isn't one MedTech market and what manufacturers need to understand before choosing where and how to enter.
    • How to choose a distributor with the right portfolio, relationships and capacity to successfully commercialise your MedTech product.
    • Why successful MedTech export requires an ongoing partnership between manufacturer and distributor, including clinical education, training, market development and clear activity plans that lead to sales.

    Listen now to learn how to commercialise and export your MedTech product successfully in the GCC by choosing the right partner, supporting them effectively and building the market for long-term adoption and growth.

    Book a 30min Healthcare Export Accelerator discovery call

    Message me via DM on Linkedin

    This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

    続きを読む 一部表示
    33 分